Kohei Kikkawa

Title: Kohei Kikkawa: Innovator in Pharmaceutical Composition for NAFLD

Introduction

Kohei Kikkawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of non-alcoholic fatty liver disease (NAFLD). His innovative work has led to the development of a unique pharmaceutical composition that addresses this growing health concern.

Latest Patents

Kikkawa holds 1 patent for his invention titled "Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease." This patent provides a pharmaceutical composition for the prophylaxis and treatment of NAFLD, comprising a 1,4-benzoxazine compound as an active ingredient. The invention also includes a method for administering a therapeutically effective amount of this compound to patients in need.

Career Highlights

Kohei Kikkawa is associated with Mitsubishi Tanabe Pharma Corporation, where he has been instrumental in advancing research and development in pharmaceutical solutions. His work focuses on innovative treatments that improve patient outcomes and address unmet medical needs.

Collaborations

Kikkawa collaborates with various professionals in the field, including his coworker Michael P Cooreman. Together, they work towards enhancing the efficacy of treatments and exploring new avenues in pharmaceutical research.

Conclusion

Kohei Kikkawa's contributions to the pharmaceutical industry, particularly in the treatment of NAFLD, highlight his role as an innovator. His patent reflects a commitment to improving health outcomes through scientific advancement.